HOME › DRUGS › CARBIDOPA
ACTIVE SUBSTANCE / INN

CARBIDOPA

Brand name(s): CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA AND LEVODOPA, CARBILEV, CREXONT, LODOSYN, CARBIDOPA, CARBIDOPA; LEVODOPA, CARBIDOPA; LEODOPA, DHIVY
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA217186
ANDA205304
ACTIVE SUBSTANCE
Carbidopa
REGULATORS
FDA
SPONSORS / MAH
IMPAX LABS, AVION PHARMS, ZYDUS PHARMS USA INC
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CARBIDOPA AND LEVODOPAANDA078893RISINGPrescription
CARBIDOPA, LEVODOPA AND ENTACAPONEANDA079085SUN PHARMDiscontinued
CARBIDOPA AND LEVODOPAANDA090631IMPAX LABSDiscontinued
CARBIDOPA; LEODOPAANDA210911ZYDUS PHARMS USA INCNone (Tentative Approval)
CREXONTNDA217186IMPAXPrescription
LODOSYNNDA017830ATONPrescription
DHIVYNDA214869AVION PHARMSPrescription
CARBILEVANDA076643RANBAXYDiscontinued
CARBIDOPA; LEVODOPAANDA208895SANDOZ INCNone (Tentative Approval)
CARBIDOPAANDA205304EDENBRIDGE PHARMSPrescription

FULL INTELLIGENCE ON CARBIDOPA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →